- work has
resulted in the
founding of
multiple companies (GlycoFi, Inc.,
Adimab LLC, Arsanis, Inc.,
Alector [Nasdaq:ALEC], Avitide, Inc., Amagma, Inc.,...
- 2018. Caroll, John (October 30, 2013). "Alzheimer's
experts team up with
Adimab, grab $10m to
launch Alector". FierceBiotech.
Retrieved 21
March 2018. Gormley...
-
Dartmouth College,
leading entrepreneur and bioengineer,
founder of
GlycoFi and
Adimab Ulrike Diebold (born 1961), Austrian–American physicist, vice president...
- to use
materials provided by
Adimab to
perform non-clinical
research during the
evaluation term.”
Merrimack has paid
Adimab a
technology access fee, research...
- a
number of the firm's
portfolio companies including Acceleron Pharma,
AdiMAB, ****nal Medical,
Ironwood Pharmaceuticals, Iora Health, Life Line Screening...
-
Corporation 2018
Arindam Bose Abiologicsb, LLC 2017
Tillman Ulf
Gerngross Adimab, LLC 2017 Mir A.
Imran Incube Labs, LLC 2017
Darlene Joy
Solomon Agilent...
-
biotechnological developments. In 2019,
scientists at a
competitor to Visterra, Inc.,
Adimab LLC, led by
Tillman Gerngross and Karl Dane
Wittrup (Sasisekharan's colleague...
-
University of
London and Atum
partnered to
develop plant-based pharmaceuticals.
Adimab LLC. and ATUM
employ an
alliance in the area of
antibody discovery and biomanufacturing...
